Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance

Go back to Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 3.46 -0.11 (3.08%)
Previous Close $3.57    52 Week High $16.89 
Open $3.52    52 Week Low $7.35 
Day High $3.54    P/E N/A 
Day Low $3.38    EPS $-2.35 
Volume 628,644